WILLIAM K OH, M.D.
Osteopathic Medicine in New York, NY

Oncology, Medical Oncology

William K Oh, MD
1190 5Th Ave, New York 10029
(212) 241-6756 (Phone), (212) 659-8539 (Fax)

Internal Medicine, 1995, Medical Oncology, 1998

Healthgrades Honor Roll

English, Spanish

Hematologist, Internist, Oncologist

1470 Madison Avenue, New York, NY 10029

English

Oh WK MD, Hayes J, Evan C, Manola J, George DJ, Waldron H, Donovan M, Varner J, Orechia J, Katcher B, Lu D, Nevins A, Wright R, Tormey L, Talcott J, Rubin M, Loda M, Sellers WR, Richie JP, Kantoff PW, Weeks JC. Development of an integrated prostate cancer information system: Prostate CRIS. Clin. Genitourin. Cancer 2006; 5(1): 61-66., Oh WK MD, Sher DJ, Jacobus S, Regan MM, Lee GS, Mantzoros C. Relationship between serum adiponectin and prostate cancer grade. Prostate 2008; 68(14): 1592-1598., Sher DJ, Mantzoros C, Jacobus S, Regan MM, Lee GS, Oh WK MD. Absence of a relationship between steroid hormone levels and tumor grade in a prospective cohort of prostate cancer. Urology 2009 Feb; 73(2): 356-361., Choueiri TC, Xie W, D’Amico AV, Ross RW, Pomerantz M, Regan MM, Taplin ME, Kantoff PW, Sartor O, Oh WK MD. Time to PSA nadir independently predicts overall survival in metastatic hormone sensitive prostate cancer patients treated with androgen deprivation therapy. Cancer 2009 Mar; 115(5): 981-987., Oh WK MD, Chan JM, Xie W, Regan MM, Stampfer MJ, King IB, Abe M, Kantoff PW. Plasma selenium, manganese superoxide dismutase (SOD2) and intermediate or high risk prostate cancer. J. Clin. Oncol. ;., Pomerantz MM, Beckwith CA, Regan MM, Stacia K, Wyman SK, Petrovics G, Chen Y, Dorota J, Hawksworth DJ, Schumacher FR, Mucci L, Penney KL, Stampfer ML, Chan JA, Ardlie KG, Fritz BR, Parkin RK, Lin DW, Dyke M, Herman P, Lee S, Oh WK MD, Kantoff PW, Tewari M, McLeod DG, Srivastava S, Freedman ML. Evaluation of the 8q24 prostate cancer risk locus and MYC expression. Cancer Research 2009 Jul; 69(13): 5568-5574., Pomerantz MM, Beckwith CA, Regan MM, Stacia K, Wyman SK, Petrovics G, Chen Y, Dorota J, Hawksworth DJ, Schumacher FR, Mucci L, Penney KL, Stampfer ML, Chan JA, Ardlie KG, Fritz BR, Parkin RK, Lin DW, Dyke M, Herman P, Lee S, Oh WK MD, Kantoff PW, Tewari M, McLeod DG, Srivastava S, Freedman ML. Evaluation of the 8q24 prostate cancer risk locus and MYC expression. Cancer Research 2009 Jul; 69(13): 5568-5574., Choueiri TK, Duh MS, Clement J, Brick AJ, Rogers MJ, Kwabi C, Shah K, Percy G, Antras L, Jayawant SS, Chen K, Wang ST, Luka A, Neary NP, McDermott D, Oh WK MD. Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety, and treatment patterns in clinical practice based on medical chart review. BJU Int.;., Oh WK MD, Landrum MB, Lamont EB, McNeil BJ, Keating NL. Does oral antiandrogen use before luteinizing hormone-releasing hormone therapy in patients with metastatic prostate cancer prevent clinical consequences of a testosterone flare? . Urology;., Regan MM, O’Donnell EK, Kelly WK, Halabi S, Berry W, Urakami S, Kikuno N, Oh WK MD. Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: A pooled analysis of 7 prospective clinical trials. Ann. Oncol.;., Regan MM, O’Donnell EK, Kelly WK, Halabi S, Berry W, Urakami S, Kikuno N, Oh WK MD. Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: A pooled analysis of 7 prospective clinical trials. Ann. Oncol.;., New York Magazine (2010), Boston Magazine 'Top Doctors' (2009), Patient's Choice Award (Vitals.com - 2008-2009), America's Top Doctors for Cancer (Castle Connolly 2008-2010), Brigham/Harvard Business School Physician Leadership Program (2007-2008), Boston Magazine 'Top Doctors' (2005), Who's Who in America (2004-2010), Best Doctors in America (2003-2010), Compassionate Caregiver of the Year, Kenneth B. Schwartz Center, Honorable Mention (2003), Prize in Internal Medicine, NYU School of Medicine (1992), Alpha Omega Alpha (1992)

American Board of Internal Medicine, Medical Oncology (Internal Medicine)

William K. Oh, M. D. is the Chief of the Division of Hematology and Medical Oncology; Professor of Medicine and Urology; and Ezra M. Greenspan, MD Professor in Clinical Cancer The...

Director at Bank of America Merrill Lynch (Corporate Bank - Leasing)

Banking

Bank of America Merrill Lynch (Corporate Bank - Leasing) - San Francisco, CA since Jul 2007 - Director UC Berkeley, Haas School of Business - Berkeley, CA Jan 2007 - May 2007 - Academic Tutor Citigroup (Private Bank) - New York, NY Jun 2006 - Aug 2006 - Summer Associate KPMG (Tax) - New York, NY Nov 1996 - Mar 2005 - Senior Manager

University of California, Berkeley - Walter A. Haas School of Business 2005 - 2007
University of Pennsylvania 1992 - 1996

Financial Analysis, Mergers, Financial Modeling, Business Development, Finance, Leadership, Management, Business Strategy, Capital Markets, Strategy, Corporate Development

Internal Medicine, Medical Oncology, Hematology & Oncology

New York University - Mount Sinai
1 Gustave L Levy Pl, New York, NY 10029 Ruttenberg Treatment Center
1470 Madison Ave, New York, NY 10029 Mt Sinai Hospital
1190 5Th Ave, New York, NY 10029

New York University (1992)